Bruker (BRKR) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.85% |
| Dec 31, 2025 | -41.75% |
| Sep 30, 2025 | 25.01% |
| Jun 30, 2025 | -16.89% |
| Mar 31, 2025 | -15.97% |
| Dec 31, 2024 | -32.03% |
| Sep 30, 2024 | -28.99% |
| Jun 30, 2024 | -54.80% |
| Mar 31, 2024 | -43.74% |
| Dec 31, 2023 | 15.65% |
| Sep 30, 2023 | -77.55% |
| Jun 30, 2023 | -9.50% |
| Mar 31, 2023 | -1.85% |
| Dec 31, 2022 | -17.47% |
| Sep 30, 2022 | -29.23% |
| Jun 30, 2022 | -0.27% |
| Mar 31, 2022 | -27.73% |
| Dec 31, 2021 | 45.20% |
| Sep 30, 2021 | -21.15% |
| Jun 30, 2021 | -43.59% |
| Mar 31, 2021 | 20.78% |
| Dec 31, 2020 | 29.24% |
| Sep 30, 2020 | -68.18% |
| Jun 30, 2020 | -20.18% |
| Mar 31, 2020 | 37.69% |
| Dec 31, 2019 | 153.23% |
| Sep 30, 2019 | 20.66% |
| Jun 30, 2019 | 20.94% |
| Mar 31, 2019 | -29.39% |
| Dec 31, 2018 | -15.86% |
| Sep 30, 2018 | -20.56% |
| Jun 30, 2018 | 7.71% |
| Mar 31, 2018 | -7.81% |
| Dec 31, 2017 | -1.90% |
| Sep 30, 2017 | 128.60% |
| Jun 30, 2017 | -38.10% |
| Mar 31, 2017 | -40.65% |
| Dec 31, 2016 | 6.50% |
| Sep 30, 2016 | 2.89% |
| Jun 30, 2016 | 22.93% |
| Mar 31, 2016 | -7.61% |
| Dec 31, 2015 | -30.27% |
| Sep 30, 2015 | 37.30% |
| Jun 30, 2015 | -195.42% |
| Mar 31, 2015 | 51.75% |